Politics · 28 Oct
రూ.15 మందును రూ.250కి అమ్ముతారా?
AI summaryThe Supreme Court questioned the Central Government and pharmaceutical traders regarding the massive price difference between the supply price and the Maximum Retail Price (MRP) of medicines in India. The court expressed severe displeasure over the alleged exploitation of patients, particularly with cancer drugs, and criticized the National Pharmaceutical Pricing Authority (NPPA) for being inactive.
1 outlet · 4 loaded terms flagged